Table 1.
Patient characteristics.
| # of Patients | 10 |
|---|---|
| Age, Median (years, range) | 65.5 (60–78) |
| Gender, N (%) | |
| Male | 7 (70) |
| Female | 3 (30) |
| Pancreas Tumor Location | |
| Head | 3 (30) |
| Body | 7 (70) |
| Tail | 0 (0) |
| RT Indication | |
| Inoperable per Surgeon | 7 (70) |
| Pre-operative RT | 1 (10) |
| Post-operative recurrence | 1 (10) |
| Consolidation in setting of de novo metastatic to liver | 1 (10) |
| Node Positive | 6 (60) |
| Pre-RT Chemotherapy* | 9 (90) |
| Induction FOLFIRINOX | 7 (70) |
| Neoadjuvant FOLFIRINOX → gem/nab-paclitaxel | 1 (10) |
| Induction gem/nab-paclitaxel | 1 (10) |
| Tumor size on pre-RT CT (cm, range) | 3.2 (1.3–4.5) |
| Average compression belt pressure (mm Hg, range) | 32.5 (25–40) |
*
1 patient received adjuvant FOLFIRINOX 2 years prior at time of initial diagnosis but received no pre-RT chemotherapy at time of recurrence.